Skip to main content
SpringerLink
Log in

Clinical Aspects and Antiviral Therapy in Primary Herpetic Gingivostomatitis

  • Review Article
  • Published:
Paediatric Drugs Aims and scope Submit manuscript

Abstract

Primary symptomatic herpes simplex virus infection in children usually manifests as gingivostomatitis and is prevalent in the 1- to 3-year age group. The disease involves the buccal and gingival mucosa and the tongue, and lasts approximately 2 weeks.

Two recent non-blind studies reported a more rapid regression of symptoms after treatment with aciclovir suspension. Three randomised double-blind, placebo-controlled trials have clearly demonstrated that early aciclovir treatment significantly shortens the duration of all clinical manifestations and infectivity of affected children compared with placebo.

We conclude that the treatment of herpetic gingivostomatitis with aciclovir is recommended. Treatment should be started within the first 3 days of disease onset. The proposed therapeutic dose is 15 mg/kg, 5 times daily for 5 to 7 days.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Fig. 1

Similar content being viewed by others

References

  1. Katz J, Marmary I, Ben-Yehuda A, et al. Primary herpetic gingivostomatitis: no longer a disease of childhood. Community Dent Oral Epidemiol 1991; 19: 309–12

    Article  PubMed  CAS  Google Scholar 

  2. Amir J, Nussinovitch M, Kleper R, et al. Primary herpes simplex virus type 1 gingivostomatitis in paediatric personnel. Infection 1997; 25(5): 310–2

    Article  PubMed  CAS  Google Scholar 

  3. Cesario TC, Poland JD, Wulff H, et al. Six years’ experience with herpes simplex virus in a children’s home. Am J Epidemiol 1969; 90: 416–22

    PubMed  CAS  Google Scholar 

  4. Schmitt DL, Johnson DW, Henderson FW. Herpes simplex type 1 infection in group day care. Paediatr Infect Dis J 1991; 10: 729–34

    Article  CAS  Google Scholar 

  5. Becker TM, Magder L, Harrison H, et al. The epidemiology of infection with the human herpes viruses in Navajo children. Am J Epidemiol 1998; 127: 1071–8

    Google Scholar 

  6. Kusushima K, Kimura H, Kino Y, et al. Clinical manifestation of primary herpes simplex type 1 infection in a closed community. Paediatrics 1991; 87: 152–8

    Google Scholar 

  7. Hale BD, Rendtorff RC, Alker LC, et al. Epidemic herpetic stomatitis in an orphanage nursery. JAMA 1963; 183: 1068–72

    Article  PubMed  CAS  Google Scholar 

  8. Amir J, Harel L, Smetana Z, et al. The natural history of primary herpes simplex type 1 gingivostomatitis in children. Paediatr Dermatol 1999; 16(4): 259–63

    Article  CAS  Google Scholar 

  9. Amir J, Yagupsky P. Invasive kingella kingae infection associated with stomatitis in children. Paediatr Infect Dis J 1988; 17: 757–8

    Article  Google Scholar 

  10. Amir J, Nussinovitch M, Straussberg R R, et al. Bacteremia with group A streptococcus associated with herpetic gingivostomatitis in children. Ped Infect Dis. In press

  11. Amir J, Straussberg R, Harel L, et al. Evaluation of a rapid enzyme immunoassay for the detection of herpes simplex antigen in children with herpetic gingivostomatitis. Paediatr Infect Dis J 1996; 15:627–9

    Article  CAS  Google Scholar 

  12. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy of herpes simplex encephalitis. N Engl J Med 1986; 314: 144–9

    Article  PubMed  CAS  Google Scholar 

  13. Whitley RJ, Hutto C. Neonatal herpes simplex virus infections. Paediatr Rev 1985; 7: 119–26

    Article  Google Scholar 

  14. Bryston YJ, Dillon M, Lovett M, et al. Treatment of first episodes of genital herpes simplex infection with oral acyclovir: a randomised double-blind controlled trial in normal subjects. N Engl J Med 1983; 308: 916–21

    Article  Google Scholar 

  15. Reichman RC, Badger GH, Mertz GI, et al. Treatment of recurrent genital herpes simplex infection with oral acyclovir: a controlled trial. JAMA 1984; 251: 2103–7

    Article  PubMed  CAS  Google Scholar 

  16. Raborn GW, McGraw WT, Grace M, et al. Oral acyclovir and herpes labialis: a randomised double-blind, placebo controlled study. J Am Dent Assoc 1987; 115: 38–42

    PubMed  CAS  Google Scholar 

  17. Mueller R, Weigand KH. The treatment of herpetic gingivostomatitis with acyclovir suspension. Der Kinderarzt 1988; 19: 1189–92

    Google Scholar 

  18. Cataldo F, Violante M, Maltese I, et al. Herpetic gingivostomatitis in children, the clinico-epidemiological aspects and findings with acyclovir treatment: a report of the cases of 162 patients. Paediatr Med Chir 1993; 15: 193–5

    CAS  Google Scholar 

  19. Ducoulombier H, Cousin J, Dewilde A, et al. Herpetic stomatatitis-gingivitis in children: controlled trial of acyclovir versus placebo. Ann Pediat (Paris) 1988; 35: 212–6

    CAS  Google Scholar 

  20. Amir J, Harel L, Smetana Z, et al. Treatment of herpes simplex gingivostomatitis with acyclovir in children: a randomised double-blind placebo controlled study. BMJ 1997; 314:1800–3

    Article  PubMed  CAS  Google Scholar 

  21. Aoki FY, Law BJ, Hammond GW, et al. Acyclovir (ACV) suspension for treatment of acute herpes simplex virus (HSV) gingivostomatitis in children: a placebo (PL) controlled double-blind trial [abstract no. 1530]. 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 1993 Oct 17–21; New Orleans (LA), 399

  22. Kuzushima K, Kudo T, Kumura H, et al. Prophylactic oral acyclovir in outbreaks of primary herpes simplex virus type infection in closed community. Paediatrics 1992; 89: 379–83

    CAS  Google Scholar 

  23. Fife KH, Cru M, Packer SC, et al. Recurrence and resistance patterns of herpes simplex virus following cessation of >6 years of chronic suppression with acyclovir. J Infect Dis 1994; 169: 133–4

    Article  Google Scholar 

  24. Kimberlin D, Powell D, Gruber W, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Paediatr Infect Dis J 1996; 15: 247–54

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics C, Schneider Children’s Medical Center of Israel, Petah Tikva and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    Jacob Amir

Authors
  1. Jacob Amir
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacob Amir.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amir, J. Clinical Aspects and Antiviral Therapy in Primary Herpetic Gingivostomatitis. Paediatr Drugs 3, 593–597 (2001). https://doi.org/10.2165/00128072-200103080-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128072-200103080-00004

Keywords

Search

Navigation